Market›Health Care›Pharmaceuticals›Pharmaceuticals
CSPC PHARMACEUTICAL ADR

CSPCY

$4.54Apr 26, 2021 – Apr 24, 2026
Health CarePharmaceuticals$13.36B
MVM
+$13.36B
TD Variance
0.077

Every news event mapped to its market reaction — 17 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2024-10-31-12.5%newsSeeking AlphaCSPC Pharmaceutical Group Limited goes ex dividend tomorrow
2026-01-30-11.0%M&AGuruFocus.comAstraZeneca Agrees Up to $18.5 Billion Obesity Drug Deal in China
2026-01-30-11.0%newsBioPharma DiveAstraZeneca leans into obesity, striking wide-ranging alliance with China’s CSPC
2026-04-01+9.8%newsPR NewswireAlphamab Oncology Announces the Phase III Clinical Study of Anbenitamab (KN026) Combined with HB1801 as Neoadjuvant Treatment for Breast Cancer Has Met the Primary Endpoint
2026-01-27+6.7%newsSimply Wall St.Is CSPC Pharmaceutical Group (SEHK:1093) Still Attractive After A 129% One-Year Share Price Surge
2026-02-14+5.1%newsPR NewswireAlphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Colorectal Cancer of Biparatopic HER2-targeting ADC JSKN003
2024-07-12-4.4%newsSeeking AlphaModerna rival CSPC cleared to study RSV shot in China
2026-03-24-4.3%newsPR NewswireAlphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study of Anbenitamab (KN026) Combined with HB1801 and Chemotherapy as Adjuvant Treatment of Breast Cancer
2023-03-22-4.2%newsSeeking AlphaChina approves emergency use of 1st home-grown mRNA COVID vaccine
2022-04-04+3.6%legalSeeking AlphaCanSino, CSPC Pharma win regulatory nod in China to start trials for mRNA COVID-19 shots
2026-02-02+3.5%M&AZacksAZN Obesity Pipeline to Get a Boost From Deal With China's CSPC
2023-03-29-2.8%newsSeeking AlphaCSPC Pharma Wins China's mRNA Vaccine Race, But Just Not Fast Enough
2026-02-01-1.7%M&ASimply Wall St.CSPC AstraZeneca Deal Recasts Role In Global Obesity And Diabetes Therapies
2023-06-29-1.6%newsSeeking AlphaPfizer in pact with CSPC to sell oral COVID therapy in China
2026-04-22-1.1%newsSimply Wall St.CSPC’s SYS6051 Trial Approval Adds New Angle To Valuation Story
2026-04-22-1.1%newsPR Newswire2026 ASCO Preview | Results from Phase III Study of Anbenitamab (KN026) Combined with HB1801 in Neoadjuvant Treatment for Breast Cancer Selected for LBA Oral Presentation
2025-07-30+1.0%newsSeeking AlphaMadrigal in-pact with CSPC Pharma for GLP-1 candidate license
tickerdossier.comtickerdossier.substack.com